FDA Inspection 908076 — SCI Pharmtech Inc.

SCI Pharmtech Inc. — FEI 3004065859

The FDA completed an inspection of SCI Pharmtech Inc. on Dec 19, 2014 in Taoyuan City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 19, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taoyuan City (Taiwan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.